αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4.
Jin ZH, Furukawa T, Degardin M, Sugyo A, Tsuji AB, Yamasaki T, Kawamura K, Fujibayashi Y, Zhang MR, Boturyn D, Dumy P, Saga T.
Jin ZH, et al. Among authors: boturyn d.
Mol Cancer Ther. 2016 Sep;15(9):2076-85. doi: 10.1158/1535-7163.MCT-16-0040. Epub 2016 Jul 15.
Mol Cancer Ther. 2016.
PMID: 27422811